View of Evaluation of tumor-infiltrating lymphocytes as a predictive biomarker of recurrence in patients with ductal carcinoma in situ of the breast

Return to Article Details Evaluation of tumor-infiltrating lymphocytes as a predictive biomarker of recurrence in patients with ductal carcinoma in situ of the breast Download Download PDF